Summary Report of Consolidated Financial Results
For the Three Months Period ended June 30, 2007 (Year ending March 31, 2008)
August 10, 2007
Company name: NIPRO
Representative:
Contact:

CORPORATION

Code No.8086
TSE/OSE–1st section
URL: http://www.nipro.co.jp/
Minoru Sano, President and Representative Director
Akihiko Yamabe, Director, General Manager of Accounting & Corporate Planning Division
TEL: (06) 6372-2331(Note: Amounts are truncated to one million yen)
1. Financial results for the three months ended June 30, 2007.(From April 1, 2007 to June 30, 2007)(1) Consolidated Results of Operations
Net(Quarter)
Net Sales
Operating Income
Recurring Income
Income3 months ended June 30,2007
3 months ended June 30,2006
Year ended March 31,2007

Millions of yen %Millions of yen %41,376 (21.1)
52,461 5.0
184,362
-

3,757
3,963
13,053

Earnings
per Share
3 months ended June 30,2007
3 months ended June 30,2006
Year ended March 31,2007

(5.2)
12.0
-

Millions of yen %

4,684
3,387
11,355

38.3
(4.4)
-

Millions of yen %

2,964
1,624
8,555

82.5
54.1
-

Diluted Earnings
per Share

Yen

Yen

46.69
25.57
134.71-

Note: The % displays show increase/decrease ratio against the same period of the previous year.

(2) Consolidated Financial Position
Total Assets
3 months ended June 30,2007
3 months ended June 30,2006
Year ended March 31,2007

Net Assets

Millions of yen

Millions of yen

344,868
324,688336,659

129,468
111,152
127,020

Cash flows fromoperating activities

Cash flows frominvesting activities

Equity Ratio

Net Assets per Share

%

37.1
33.6
37.3

Yen

2,017.58
1,715.15
1,979.21(3) Consolidated Cash Flows

Millions of yen
3 months ended June 30,2007
3 months ended June 30,2006
Year ended March 31,2007(2,023)
4,626
14,488Millions of yen(8,087)(4,986)(2,924)

Cash flows fromfinancing activities
Millions of yen(2,875)(12,859)(15,654)

Cash and cash
equivalents
Millions of yen

33,36536,772
46,109

2. Projected Consolidated Financial Results for the Year ending March 31, 2008 (From April 1, 2007 to March 31, 2008)
The figures of the projected consolidated financial results for the year ending March 31, 2008 (From April 1, 2007 to
March 31, 2008) or for the six-month period ending September 30, 2007, announced on May 18, 2007, have not beenchanged.

-1-3. Others(1) Change in significant subsidiaries during the year ended June 30, 2007(Resulting in a change in scope of
consolidation): None
(2) Adoption of simplified accounting treatments: None
(3) Difference in the method of accounting treatment from the most recent fiscal year: None

*Disclaimer regarding projection information including appropriate use of forecasted financial results, and otherspecial notes
The projection figures shown above are based on information that was available at the time of preparation andmay contain certain uncertainties. Actual performance and other factors may differ from these projections due
to changes in circumstances and other developments. More information concerning these forecasts can befound on page 3 in the attachments.

-2-

[Qualitative information, financial statements and others]
1.

Qualitative information on the consolidated results of operation
The situation of Japanese economy for this three-month period generally remained in the trend of gradualexpansion due to the steady individual consumptions and capital investments, while we were afraid of a negative
impact from the continuous high oil prices and the rise of the interest rate. Under such situation, we have madeeffort to reinforce our production capacity and selling capability to enhance our revenues.
As a result, net sales for the three months ended June 30, 2007 was 41,376 million yen, decreased by 21.1%
from the same period of the previous fiscal year due to no sales from store business, which had the sales of 16,127
million yen in the same period of the previous fiscal year but we withdrew from the retail division in the previous
fiscal period. The sales of Medical Equipment business was 26,440 million increased by 17.1% from the same
period of the previous fiscal year, the sales of Pharmaceutical business was 12,060 million yen increased by 22.1%
from the same period of the previous fiscal year, the sales of Glass and Materials business was 2,660 million yen
decreased by 25.0% from the same period of the previous fiscal year, and the sales of other business was 215
million yean decrease by 35.6% from the same period of the previous fiscal year.
Operating income decreased by 5.2% from the same period of the previous fiscal year to 3,757 million yen, whilerecurring income increased by 38.3% from the same period of the previous fiscal year to 4,684 million yen due tothe accrual of foreign exchange gain and net quarter income increased by 82.5% from the same period of theprevious fiscal year to 2,964 million yen.

2.

Qualitative information on the consolidated financial position
Total assets increased by 8,209 million yen to 344,868 million yen from the end of previous fiscal year. Current
assets decreased by 7,916 million yen and fixed assets increased by 16,125 million yen from the end of previous
fiscal year. Current assets decreased mainly due to the decrease of 12,746 million yen in the cash on hand inbanks and fixed assets decreased mainly due to the increase of 12,559 million yen in the tangible fixed assets.
Total liabilities increased by 5,761 million yen to 215,400 million yen. Current liabilities increased by 16,327
million yen and fixed liabilities decreased by 10,565 million yen. Current liabilities increased mainly due to increaseof 10,000 million yen in current portion of bonds and fixed liabilities decreased mainly due to decrease of 10,000
million yen in bonds.
Net assets increased by 2,447 million yen to 129,468 million yen from the end of previous fiscal year.

3.

Qualitative information on the state of the consolidated cash flow
Cash flow used in operating activities amounted to 2,023 million yen mainly reflecting income taxes paid, cash
flow used in investing activity amounted to 8,087 million yen mainly due to payments for acquisition of fixed assets
for 8,324 million yen, and cash flow used in financing activities also amounted to 2,875 million yen of payment
exceeds mainly due to repayment of long-term borrowings. As a result, cash and cash equivalents at the end of
the period amounted to 33,365 million yen decreased by 12,744 million yen from the end of previous fiscal year.

4.

Qualitative information on the projected consolidated financial results
The business environment is anticipated to remain severe due to worry about rise of oil prices and increase ofinterest rates. We, however, continuously endeavor to develop new products, as well as to reinforce theproduction capacity and selling capability in order to enhance our revenues.
Thus, the figures of the projected consolidated financial results for the year ending March 31, 2008 (From April 1,
2007 to March 31, 2008) announced on May 18, 2007, have not been changed.

5.

Others(1) Change in significant subsidiaries during the year ended June 30, 2007(Resulting in a change in scope of
consolidation): None
(2) Adoption of simplified accounting treatments: None
(3) Difference in the method of accounting treatment from the most recent fiscal year: None

- 3 -

4. Summary of Quarter Consolidated Financial Statements(1) Summary of Quarter Consolidated Balance Sheets for the Three Months Period ended June 30, 2007 (Year ending
March 31, 2008)(Note: Amounts are truncated to one million yen)Account

As of

As of

As of

June 30, 2006

June 30, 2007

March 31, 2007

AmountAmountAmount

Ratio

Ratio

Ratio

Change in amountAmountChangeRatio(ASSETS)%%

133,584

Cash on hand and in banks

39,51435,18847,934( 12,746)

Trade notes and accounts

47,36852,57750,972

1,604

Inventories

41,09244,282

40,213

4,069

Deferred tax assets

1,610

2,725

3,033

(308)

Other current assets

4,245

5,052

5,581

(528)

Allowance for doubtful

(247)

(509)

(501)

(7)

40.4

147,233%

Current Assets

41.1

139,317%
43.7( 7,916)(5.4)

receivableaccounts

Fixed Assets

191,10458.9

205,55159.6

189,426

56.3

16,125

8.5

Tangible fixed assets

112,659

34.7

117,440

34.0

104,88131.2

12,55912.0

Buildings and structures

44,631

39,68938,113

1,575

Machinery and vehicles

29,01032,046

31,105941

Land23,96019,124

18,032

1,091

Construction in progress

10,203

21,614

12,856

8,757

Others

4,854

4,966

4,773

193

Intangible fixed assets

1,653

0.5

2,615

0.8

1,902

0.6

712

Goodwill

341

949

240

708

Others

1,311

1,665

1,661

4

Investments and other assets

76,791

Investment securities

59,94080,33277,304

3,028

Long-term loans

2,371

282

303

(21)

472

69

61

7

Lease deposits

10,786

4,576

4,791

(215)

Other assets

4,332

3,254

3,198

56

(1,111)(3,018)(3,017)(1)

23.7

85,49524.8

82,642

24.5

2,853

37.5

3.5

receivable
Deferred tax assets

Allowanceaccounts

Total Assetsfordoubtful

324,688100.0

344,868

100.0

336,659

100.0

8,209

(Note) Change in amount represents the comparison between June 30, 2007 and March 31, 2007.

- 4 -

2.4

(Note: Amounts are truncated to one million yen)Account(LIABILITIES)Current liabilities
Trade notes andaccounts payable
Short-term borrowings
Current portion of bonds
Other payables
Accrued income taxes
Allowance for bonuses
payableAllowance for bonuses
payable for directors
and corporate auditor
Allowance for loss on
clearance of businessNotes payable for plantand equipment
Commercial paper
OthersFixed liabilities
Bonds
Convertible bond type bonds
stock acquisition rights

Long-term borrowings
Deferred tax liabilities
Accrued pension andseverance cost
Other fixed liabilities
Total liabilities

As of

As of

As of

June 30, 2006

June 30, 2007

March 31, 2007

AmountAmountAmount103,02132,688

Ratio

%
31.7

120,431
29,681

Ratio

%
34.9

104,104
26,547

Ratio

%
30.9

Change in amountAmount16,3273,134

44,632
60
4,471
1,323
871

55,252
10,060
4,696
2,251
977

50,209
60
6,123
8,404
1,461

5,043
10,000(1,427)(6,152)
(483)

-

1

230

(229)

-

1,954

1,954

-

3,582

4,668

3,655

1,013

9,000
6,391
110,51331,51014,00010,887
94,96821,45014,0005,457
105,534
31,45014,0005,429(10,565)(10,000)
-

34.1

27.6

31.4

46,818
11,7993,093

36,946
18,6602,577

38,765
17,4172,564(1,819)
1,243
13

3,292

1,334

1,336

(2)

Change
Ratio

%
15.7

(10.0)

213,53565.8

215,400

62.5

209,639

62.3

5,761

2.7

92,47728,66329,972
34,511(669)
16,466

28.4
8.8
9.2
10.6
(0.2)
5.1

97,643
28,66329,97339,764(757)
30,429

28.3
8.3
8.7
11.5
(0.2)
8.8

97,044
28,66329,97339,148(741)
28,606

28.8
8.5
8.9
11.6
(0.2)
8.5

599
0
615
(16)
1,822

0.6
0.0
1.6
2.2
6.4

20,811

6.4

31,7779.2

29,883

8.9

1,893

6.3

(4,344)(1.3)(1,347)(0.4)(1,276)

(0.4)

(70)

5.6

2,208

0.7

1,394

0.4

1,369

0.4

25

1.9

Total Net Assets

111,15234.2

129,46837.5

127,020

37.7

2,447

1.9

Total Liabilities and Net Assets

324,688100.0

344,868

100.0

336,659

100.0

8,209

2.4

(Net Assets)
Shareholders’ Equity
CapitalCapital surplus
Earned surplus
Treasury stock
Valuation and translationdifferences
Valuation differences ofother securities
Foreign currencytranslation adjustments
Minority interests(Note) Change in amount represents the comparison between June 30, 2007 and March 31, 2007.

- 5 -(2) Summary of Quarter Consolidated Statements of Income for the Three Months Period ended June 30, 2007 (Yearending March 31, 2008)(Note: Amounts are truncated to one million yen)Previous Period(From April 1, 2006
To June 30, 2006)

Current Period(From April 1, 2007
To June 30, 2007)

Change in amountAmountRatio

AmountRatio

AmountNet sales
Cost of goods sold52,461
37,624

%
100.0
71.7

41,37629,470

%
100.0
71.2

(11,085)(8,154)Gross profit
Selling, general andadministrative expenses
Operating income
Non-operating income
Interest income
Dividend income
Exchange gain
OthersNon-operating expenses
Interest expenses
Depreciation
Exchange loss
Equity in loss of affiliate
Others

14,836
10,872

28.3
20.7

11,905
8,148

28.8
19.7

3,963
461
47
294
118
1,037
431
74
280
154
96

7.6
0.9

3,757
1,592
94
312
1,003
182
666
440
28
166
30

9.1
3.8

Recurring income
Extraordinary gains
Gain on sale of fixed assets
Governmental subsidies
received
Gain on sale ofinvestment securities
Reversal of allowancefor bonus payables
Life insurance income
OthersExtraordinary losses
Loss on sale anddisposal of fixed assets
Impairment loss on fixed assets
Allowance for loss on
clearance of business
Loss on investment securities
Loss on disposal of inventories
Abnormal manufacturing cost
Advanced depreciation
on fixed assets
Allowance for doubtful debts
OthersNet(Quarter) income before
adjustment of taxes
Corporate, inhabitants andenterprise taxes
Adjustment for deferred taxes
Minority shareholders’ sharein net income of consolidated
subsidiaries
Net(Quarter) income

3,387
29
12
-

6.5
0.1

4,684
223
4
1

11.3
0.6

Account

2.0

1.6

ChangeRatio

Previous Period(From April 1, 2006
To March 31, 2007)
AmountRatio%(21.1)(21.7)

184,362
132,142

%
100.0
71.7

(2,930)(2,724)(19.8)(25.1)

52,22039,167

28.3
21.2

(205)
1,131
46
17
1,003
64
(371)
8
(45)
(280)
12
(66)

(5.2)
245.5

13,053
1,657
308
560
313
475
3,355
1,645
381
791
537

7.1
0.9

11,355
13,660
30
661

6.2
7.4

1,296
194
(7)
1

(35.8)

38.3

-

-

-

12,706

2

18

16

2

15
398
49

191
7
122
34

191
(7)
(275)
(15)

259
8,240
516

0.8

0.3

1.8

4.5

-

-

-

1,286
1,954

268
17
50
-

12
27
1

(268)
(5)
(23)
1

268
253
246
650

12
3,018

5.8

47
4,785

11.6

35
1,767

2,361
703
16,775

9.1

780

1.5

1,425

3.4

644

10,059

5.5

549
64

1.1
0.1

372
23

0.9
0.1

(176)
(41)

(1,873)
33

(1.0)
0.0

1,624

3.1

2,964

7.2

1,339

8,555

4.6

58.6

82.5

(Notes) Change in amount represents the comparison betweem three months ended June 30, 2007 and three month ended June 30,
2006

- 6 -

(3) Consolidated Statement of Shareholders’ Equity
Previous period (From April 1, 2006 to June 30, 2006)(Note: Amounts are truncated to one million yen)
Shareholders’ equity
CapitalCapitalEarnedTreasury

surplussurplusstock

29,972

34,545

(648)

Total
shareholders'equityBalance at March 31, 2006

28,66392,532

Increase (decrease) during the period

Dividend of surplus
Bonusestodirectors

and(1,365)(91)(1,365)
(91)

1,624

1,624
(21)
0

corporate auditors
Net(Quarter) income(21)0Acquisition of treasury stock0

Disposal of treasury stock
Decrease in earned surplus due to(201)

addition of consolidated subsidiaries(201)

Increase (decrease) of the items other than-shareholders’ equity during the period

28,663

Net increase (decrease) during the period

Balance at June 30, 2006

029,972(33)
34,511

(20)
(669)

(54)
92,477

Minority

Total net

interests

assets

1,612

114,003

Valuation and translation differences

Balance at March 31, 2006

Valuation

Foreign

Total

differences ofcurrency

valuation andothertranslationtranslation

securities

adjustments

differences

25,563(5,705)19,858

Increase (decrease) during the period

Dividend of surplus-(1,365)-(91)

Net(Quarter) income

-

1,624

Acquisition of treasury stock

-

(21)

Disposal of treasury stock

-

0

-

(201)

Bonusestodirectors

andcorporate auditors

Decrease in earned surplus due toaddition of consolidated subsidiaries
Increase (decrease) of the items other than

(4,752)

1,360(3,392)596(2,795)

Net increase (decrease) during the period(4,752)

1,360(3,392)596(2,850)

Balance at June 30, 2006

20,811(4,344)

16,4662,208

111,152

shareholders’ equity during the period- 7 -Current period (From April 1, 2007 to June 30, 2007)(Note: Amounts are truncated to one million yen)
Shareholders’ equity
CapitalBalance at March 31, 2007

28,663

CapitalEarnedTreasury

surplussurplusstock

29,97339,148

(741)

Total
shareholders'equity97,044

Increase (decrease) during the period

Dividend of surplus(2,348)Net(Quarter) income

2,964

Acquisition of treasury stock
Disposal of treasury stock0(2,348)
2,964
(17)

(17)

1

1

Increase (decrease) of the items other than-shareholders’ equity during the period

-

0

615

(16)

599

28,66329,97339,764(757)

97,643

Net increase (decrease) during the period

Balance at June 30, 2007

Valuation and translation differences

Balance at March 31, 2007

Valuation

Foreign

Total

differences ofcurrency

valuation andothertranslationtranslation

securities

adjustments

differences

29,883(1,276)28,606

Minority

Total net

interests

assets1,369

127,020

Increase (decrease) during the period

Dividend of surplus-(2,348)Net(Quarter) income

-

2,964

Acquisition of treasury stock

-

(17)

Disposal of treasury stock-

1

Increase (decrease) of the items other than

1,893

(70)

1,822

25

1,848

Net increase (decrease) during the period

1,893

(70)

1,822

25

1,848

Balance at June 30, 2007

31,777(1,347)30,4291,394

129,468

shareholders’ equity during the period- 8 -Previous period (From April 1, 2006 to March 31, 2007)(Note: Amounts are truncated to one million yen)
Shareholders’ equity
CapitalBalance at March 31, 2006

28,663

CapitalEarnedTreasury

surplussurplusstock

29,972

34,545

(648)

Total
shareholders'equity92,532

Increase (decrease) during the period

Dividend of surplus
Bonuses to directors andcorporate auditors
Net income(4,096)(91)(4,096)
(91)

8,555

8,555
(101)
10

Acquisition of treasury stock
Disposal of treasury stock

1

Increase in earned surplus due todivestiture of consolidated subsidiaries
Decrease in earned surplus due toaddition of consolidated subsidiaries
Increase (decrease) of the items other than shareholders’ equity during the period
Net increase (decrease) during the period

Balance at March 31, 2007

(101)
9
436

436

(201)

(201)
-

28,663

1
29,973

4,602
39,148

(92)
(741)

4,512
97,044

Minority

Total net

interests

assets

1,612

114,003

Valuation and translation differences

Balance at March 31, 2006

Valuation

Foreign

Total

differences ofcurrency

valuation andothertranslationtranslation

securities

adjustments

differences

25,563(5,705)19,858

Increase (decrease) during the period

Dividend of surplus-

Bonuses to directors andcorporate auditors
Net income-(4,096)
(91)

-

8,555
(101)
10

-

436

-

(201)

Acquisition of treasury stock
Disposal of treasury stock
Increase in earned surplus due todivestiture of consolidated subsidiaries
Decrease in earned surplus due toaddition of consolidated subsidiaries
Increase (decrease) of the items other than shareholders’ equity during the period
Net increase (decrease) during the period

Balance at March 31, 2007

4,319

4,428

8,748

(243)

8,505

4,319
29,883

4,428(1,276)

8,748
28,606

(243)
1,369

13,017127,020- 9 -(4) Summary of Quarter Consolidated Statements of Cash Flow
(Note: Amounts are truncated to one million yen)

Division

Previous Period(From April 1, 2006
To June 30, 2006)

Current Period(From April 1, 2007
To June 30, 2007)

Previous Period(From April 1, 2006
To March 31, 2007)

AmountAmountAmountCash flows from operating activities
Net income before adjustment for taxes
Depreciation and amortization
Impairment loss on fixed assets
Amortization of goodwill
Equity in loss of affiliate
Allowance for doubtful debts
Allowance for loss on clearance of business
Increase (decrease) in allowance for
doubtful accounts
Interest and dividend income
Interest expenses
Exchange loss (gain)
Gain on sales of shares of subsidiary company
Decrease (increase) in trade receivables
Decrease (increase) in inventories
Increase (decrease) in trade payables
Decrease (increase) in other assets
Increase (decrease) in other liabilities
Bonuses to directors and corporate auditors
Other non-operating income/expenses andextraordinary gains/losses
SubtotalInterest and dividends received
Interest paid
Other revenues
Other expenditures
Income taxes paid
Cash flows from operating activities
Cash flows from investing activities
Deposits in time deposits
Proceeds from matured time deposits
Payments for purchases of securities
Proceeds from sales of securities
Payments for acquisition of shares with change
In scope of consolidated subsidiary
Proceeds from sales of shares with change inscope of consolidated subsidiary
Payments for acquisition of fixed assets
Proceeds from sales of fixed assets
Increase(decrease) in short-term lending
Collections of loans receivable
Expenditures for other investments
Revenues from other investments
Cash flows from investing activities
Cash flows from investing activities
Net increase (decrease) in short-term borrowings
Net increase (decrease) in commercial paper
Proceeds from long-term borrowings
Repayment of long-term borrowings
Payments for redemption of bonds
Proceeds from issuance of shares
Proceeds from disposal of treasury stock
Payments for acquisitions of treasury stock
Repayments of finance lease obligations
Payments for dividends
Other payments
Cash flows from financing activities
Effect of exchange rate changes on cash and cash
equivalents
Increase (decrease) in cash and cash equivalents
Balance of cash and cash equivalents at the
beginning of the period
Increase in cash and cash equivalents due toinclusion of new subsidiary in consolidation
Balance of cash and cash equivalents at the end of the period- 10 -

3,018
2,878
19
154
60

4,785
3,174
49
166
9

16,775
12,469
1,286
129
791
2,361
1,954
(92)

(342)
431
20
50
529
151
465
(383)
(96)
257

(406)
440
(65)
(228)
(3,328)2,222
606(2,304)
(274)

(868)
1,645
(68)
(12,706)(2,186)(3,061)(1,982)
(565)
2,678
(96)
882

7,213
296
(506)
383
(109)
(2,650)

4,844
400
(425)
600
(67)
(7,375)

19,347830(1,697)1,590(262)(5,320)4,626(2,023)

14,488

(993)
1,909
(0)
24
(517)

(551)
551
(10)
(2,479)(5,792)
7,665(2,244)24(1,220)--19,372(5,174)
2
(294)
16
40
(4,986)(5,422)
34
(245)
13
(0)
21
(8,087)(19,911)273(1,078)59(112)
40(2,924)1,002
700(3,307)(10,000)
0
(21)
(77)
(1,155)(0)(12,859)
0

827
1,445
(3,067)
3
1
(17)
(15)
(2,039)(14)(2,875)241

121(9,000)20,853(13,181)(10,060)
10
(101)
(205)
(4,090)(0)(15,654)208(13,218)
49,914(12,744)
46,109(3,881)
49,91477-

77

36,77233,365

46,109(5) Segment information[Segment information by business category]Previous period (From April 1, 2006 to June 30, 2006)
MedicalPharmaEquipment ceutical
Net sales(1)Sales to third parties(2)Inter-segment sales
and transfers(Note: Amounts are truncated to one million yen)

Glass &
Materials

Store

Other

Total

Eliminations
Consolidated/Corporate

22,573

9,876

3,549

16,127334

52,461-

52,461

3

-

817

-

130

951

(951)

-

Total

22,576

9,876

4,367

16,127464

53,412(951)

52,461

Operating expenses

18,752

9,136

3,833

15,883379

47,985511

48,497

Operating income(loss)

3,824

740

533

244

84

5,427

(1,463)

3,963

Current period (From April 1, 2007 to June 30, 2007)(Note: Amounts are truncated to one million yen)

MedicalEquipment

Pharmaceutical

Glass &
Materials

Other

Total

26,44012,0602,660

215

41,376-

41,376

-

-

852

32

885

(885)

-

Total

26,44012,0603,513

247

42,261(885)

41,376

Operating expenses

22,55010,981

3,042

225

36,800818

37,618Operating income(loss)

3,889

1,079

471

22

5,461

(1,704)

3,757

Net sales(1)Sales to third parties(2)Inter-segment sales
and transfers

Previous period (From April 1, 2006 to March 31, 2007)

Eliminations/Corporate

Consolidated(Note: Amounts are truncated to one million yen)

MedicalPharmaEquipment ceutical

Glass &
Materials

Store

Other

Total

97,30042,152

12,91830,973

1,017

184,362-

184,362

3

-

3,445

-

220

3,668

(3,668)-

Total

97,30342,152

16,36430,973

1,238

188,031(3,668)184,362

Operating expenses

82,97038,854

14,49830,702

1,087

168,113

3,195

171,309

Operating income(loss)

14,333

3,298

1,865

270

150

19,918(6,864)

13,053

Net sales(1)Sales to third parties(2)Inter-segment sales
and transfers- 11 -

Eliminations
Consolidated/Corporate

(Notes) 1. Classification of business categories and main products in each business category
Business categories are classified based on the proximity in terms of purposes and manners of usage ofthe products in the market.
Main products belonging to each business categories are as follows:Business
category
MedicalEquipment
Pharmaceutical

Glass &
Materials
Store
Other

Main products and commodities
Dialyzers, blood tubing sets, injection needles, syringes, and infusion sets, etc
Half-type and full-type kits, double-bag kits, pre-filled syringes, dialysate solution, andcirculatory drugs, etc.
Glass for pharmaceutical containers, glass for thermos bottles, glass for lighting
purposes, stoppers for plastic containers and rubber stoppers, etc.
Fresh meat and fish, vegetables, fruits, processed food, daily foods, frozen foods,
general groceries and medicine, etc.
Machinery for manufacture of medical equipment and real estate rental income, etc.

2. Operating expenses of “Eliminations/Corporate” for the consolidated accounting periods of the threemonth ended June 30, 2006, the three month ended June 30, 2007, and the year ended March 31, 2007
included unallocated corporate costs of 1,463 million yen, 1,704 million yen, and 6,864 million yen
respectively.
The unallocated corporate costs consisted primarily of the parent company’s research and development
costs and headquarters administration costs.

- 12 -

[Segment information by geographical area]
Previous period (From April 1, 2006 to June 30, 2006)
Japan

Net sales(1)Sales to third parties(2)Inter-segment sales
and transfers

America(Note: Amounts are truncated to one million yen)

Europe

Asia

Total

Eliminations
Consolidated/Corporate

46,527

3,185

1,635

1,111

52,461-

52,461

5,340

163

4

2,722

8,231

(8,231)-

51,868

3,349

1,640

3,833

60,692(8,231)

52,461

Operating expenses

46,623

3,542

1,598

3,568

55,332(6,834)

48,497

Operating income(loss)

5,245

(193)

42

265

5,360

(1,396)

3,963

Total

Current period (From April 1, 2007 to June 30, 2007)
Japan

Net sales(1)Sales to third parties(2)Inter-segment sales
and transfers

America(Note: Amounts are truncated to one million yen)

Europe

Asia

Total

Eliminations
Consolidated/Corporate

33,069

4,791

2,165

1,350

41,376-

41,376

6,689

328

2

3,287

10,308(10,308)-

39,758

5,120

2,168

4,637

51,684(10,308)

41,376

Operating expenses

33,685

5,419

2,082

4,402

45,589(7,971)

37,618Operating income(loss)

6,072

(299)

85

235

6,094

(2,337)

3,757

Total

Previous period (From April 1, 2006 to March 31, 2007)
Japan

Net sales(1)Sales to third parties(2)Inter-segment sales
and transfers

America(Note: Amounts are truncated to one million yen)

Europe

Asia

Total

Eliminations
Consolidated/Corporate

156,042

17,382

7,102

3,835

184,362-

184,362

23,610804

86

12,37336,875(36,875)-

179,653

18,186

7,188

16,208221,238(36,875)

184,362

Operating expenses

159,255

19,133

7,050

15,755201,193(29,884)

171,309

Operating income(loss)

20,398

(946)

138

453

20,044(6,991)

13,053Total- 13 -

(Note) 1. Operating expenses of “Eliminations/Corporate” for the consolidated accounting periods of the threemonth ended June 30, 2006, the three month ended June 30, 2007, and the year ended March 31, 2007
included unallocated corporate costs of 1,463 million yen, 1,704 million yen, and 6,864 million yen
respectively.
The unallocated corporate costs consisted primarily of the parent company’s research and development
costs and headquarters administration costs.
2.

Classification of countries or areas is based on geographical proximity.

3.

The major countries included in each geographical area are as follows:
America…….. The United States of America and Brazil
Europe……… Belgium
Asia…………. China, Thailand and Singapore[Overseas Sales]
Previous period (From April 1, 2006 to June 30, 2006)
America

1. Overseas sales(Note: Amounts are truncated to one million yen)
Europe

6,846

3,415

Asia

2,045

2. Consolidated net sales
Percentage of overseas sales

3. to consolidated net sales (%)

13.1%

America

6.5%

Percentage of overseas sales

4,856

Asia

2,050

20.8%

America

11.7%

Percentage of overseas sales

15,53237.5%(Note: Amounts are truncated to one million yen)
Europe31,8995.0%

15,071

Asia

7,567

Total

54,538184,362

2. Consolidated net sales
3. to consolidated net sales (%)

Total

41,376

Previous period (From April 1, 2006 to March 31, 2007)

1. Overseas sales

23.5%(Note: Amounts are truncated to one million yen)
Europe

8,625

3.9%

2. Consolidated net sales
3. to consolidated net sales (%)

12,30752,461

Current period (From April 1, 2007 to June 30, 2007)

1. Overseas sales

Total

17.3%

8.2%

4.1%

29.6%

(Notes) 1. Overseas sales represent those of the Company and the consolidated subsidiaries to countries
and areas outside of Japan
2. Classification of countries or areas is based on geographical proximity.
3. The major countries included in each geographical area are as follows:
America………The United States of America, Canada and Brazil
Europe………. Belgium, Denmark and Germany
Asia………….. China, India, Indonesia, Taiwan and Thailand- 14 -

5. Production, Orders received and Sales(1) Production(Note: Amounts are truncated to one million yen)
Business segment

Previous Period(From April 1, 2006
To June 30, 2006)
Amountproduced

Current Period(From April 1, 2007
To June 30, 2007)

Ratio of change
from the previous
period (%)

Amountproduced

Previous Period(From April 1, 2006
To March 31, 2007)

Ratio of change
from the previous
period (%)

Amountproduced

Ratio of change
from the previous
period (%)

Medical Equipment

17,397

8.6

19,503

12.1

73,011

11.5

Pharmaceutical

9,773

36.7

12,311

26.0

41,744

16.4

Glass & Materials

810(13.3)

812

0.1

3,253

(4.8)

Other

222

1,179.3

199(10.2)

700(23.3)

Total

28,20416.9

32,826

16.4

118,709

12.4(Notes) 1. Amounts produced are calculated based on average selling prices.
2. The above amounts are after eliminations of the inter-segment transactions.
3. The above amounts do not include the related consumption taxes etc.

(2) Orders received
Since we adopt the production system based on estimated orders, there is nothing applicable hereto regarding
the amount and the balance of orders received.
(3) Sales(Note: Amounts are truncated to one million yen)
Business segment

Previous Period(From April 1, 2006
To June 30, 2006)

Current Period(From April 1, 2007
To June 30, 2007)

Ratio of change

Previous Period(From April 1, 2006
To March 31, 2007)

Ratio of change

Ratio of change

Amount sold from the previous Amount sold from the previous Amount sold from the previous
period (%)

period (%)

period (%)

Medical Equipment

22,573

1.5

26,44017.1

97,3007.1

Pharmaceutical

9,876

44.7

12,06022.1

42,152

19.7

Glass & Materials

3,549

22.5

2,660

(25.0)

12,9188.3

Store16,127

(7.5)

-

-

30,973(54.0)

Other

334(41.4)

215(35.6)

1,017(33.0)

Total

52,461

5.0

41,376(21.1)

184,362(10.9)(Notes) 1. The above amounts are after eliminations of the intersegment transactions.
2. The above amounts do not include the related consumption taxes etc.

- 15 -